| 1. | | Recruiting | Administration of EBV-Specific Cytotoxic T-Lymphocytes to Patients with EBV-Positive Cancer of the Nose and Throat
Conditions: Nasopharyngeal Cancer; Epstein-Barr Virus Infections |
| 2. | | Recruiting | Anti-Human CD45 Monoclonal Antibodies in Patients with Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation
Condition: Leukemia |
| 3. | | Recruiting | Autologous Cytotoxic T-Lymphocytes in Treating Patients With Relapsed Epstein-Barr Virus-Associated Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
Conditions: recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma; primary central nervous system lymphoma; ... |
| 4. | | Recruiting | Bexarotene in Preventing Breast Cancer in Women at Genetic Risk
Condition: Breast Cancer |
| 5. | | Recruiting | Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
Condition: Neuroblastoma |
| 6. | | Terminated | Bone marrow transplant from donor using less toxic conditioning for patient with high risk hemoglobinopathies
Conditions: Sickle Cell Anemia; Hemoglobinopathy; Thalassemia |
| 7. | | Terminated | Bone Marrow transplant from related donor for patients with high risk hemoglobinopathies
Conditions: Sickle Cell Anemia; Hemoglobinopathy; Thalassemia |
| 8. | | Recruiting | Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)
Condition: Hereditary Ataxia |
| 9. | | Recruiting | Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients with Hematological Diseases
Condition: Hematologic Malignancy |
| 10. | | Recruiting | Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus after Allogeneic Stem Cell Transplant
Conditions: Stem Cell Transplantation; Cytomegalovirus Infections |
| 11. | | Recruiting | EBV-Specific CTLs Following CD45 Antibody to Patients with Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)
Conditions: Nasopharyngeal Cancer; EBV Infections |
| 12. | | Recruiting | The Effect of Oral Magnesium Pidolate on How Often Painful Crises Happens in Patients with Hemoglobin SC Disease
Condition: Hemoglobin SC Disease |
| 13. | | Recruiting | Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 14. | | Recruiting | Gene Marked Cytotoxic T-cells for Patients with Relapsed Hodgkin's Lymphoma
Condition: Hodgkin Disease |
| 15. | | Recruiting | Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients who have had Donor Marrow Grafts.
Conditions: Bone Marrow Transplantation; Epstein-Barr Virus Infections |
| 16. | | Recruiting | Giving Gene Marked (Optional) Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells to Patients with Relapsed EBV-Positive Lymphoma,
Conditions: Hodgkins Disease; Non-Hodgkins Lymphoma |
| 17. | | Recruiting | Giving Gene Marked Epstein Barr Virus (EBV) Specific T-Cells to Patients Receiving a Bone Marrow Transplant (BMT) for Relapsed EBV-Positive Hodgkin Disease
Conditions: Hodgkin Disease; Non-Hodgkins Lymphoma |
| 18. | | Recruiting | Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion
Conditions: Infant, Low Birth Weight; Hyperglycemia |
| 19. | | Terminated | High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients with Multiple Sclerosis
Condition: Multiple Sclerosis |
| 20. | | Recruiting | Intrathecal Gemcitabine to Treat Neoplastic Meningitis
Conditions: Meningitis; Neoplasms |
| 21. | | Recruiting | Intrathecal Mafosfamide
Condition: Malignant Meningeal Neoplasms |
| 22. | | Recruiting | LMP2a-Specific Cytotoxic T-Lymphocytes Following CD45 Antibody for Lymphoma
Condition: Lymphoma |
| 23. | | No longer recruiting | Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer
Conditions: squamous cell carcinoma of the skin; prevention of skin cancer; basal cell carcinoma of the skin |
| 24. | | Recruiting | Low-Dose Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Allogeneic Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorder or Myelodysplastic Syndrome
Conditions: Polycythemia Vera; Essential Thrombocythemia; de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; ... |
| 25. | | Terminated | Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients with Inherited Metabolic Storage Diseases
Condition: Inherited Metabolic Storage Diseases |
| 26. | | Recruiting | A Monoclonal Antibody Conditioning Regimen for Allogeneic Stem Cell Transplant in Patients with Fanconi Anemia.
Condition: Fanconi's Anemia |
| 27. | | No longer recruiting | Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy
Condition: Neuroblastoma |
| 28. | | Completed | Nutritional Aspects of Rett Syndrome
Condition: Rett Syndrome |
| 29. | | Recruiting | A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients
Condition: Neoplasms |
| 30. | | Completed | Phase II Randomized Study of Leuprolide vs Oral Contraceptive Therapy vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism
Condition: Hyperandrogenism |
| 31. | | Completed | Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women with Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
Conditions: Acanthosis Nigricans; Polycystic Ovary Syndrome |
| 32. | | Completed | Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension
Condition: Hypertension, Pulmonary |
| 33. | | Recruiting | Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).
Conditions: Epstein-Barr Virus Infections; Lymphoproliferative Disorders |
| 34. | | Completed | Stem Cell Transplant for Patients with Blood Malignancy Using Donors and Less Toxic Chemotherapy with CAMPATH 1H
Conditions: Myelodysplastic Disorders; Leukemia; Multiple Myeloma; Plasma Cell Dyscrasia; Lymphoproliferative Disorders |
| 35. | | Recruiting | Stem Cell Transplant for Patients with Hematologic Diseases and Renal Cell Cancer Using Family Donors and Conditioning with Campath-1H
Condition: Hematologic Malignancies |
| 36. | | Completed | Stem Cell Transplant to Treat Patients with Systemic Sclerosis
Condition: Systemic Sclerosis |
| 37. | | Terminated | Stem Cell Transplantation for Patients with Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning with CAMPATH 1H
Condition: Graft Failure |
| 38. | | Completed | Study of Cardiac and Paroxysmal Abnormalities in Rett Syndrome
Condition: Rett Syndrome |
| 39. | | Recruiting | Study of Irinotecan in Children.
Condition: Cancer |
| 40. | | Recruiting | Study of Neurobehavioral Outcome in Children or Adolescents With Closed Head Injuries
Condition: Head Injuries, Closed |
| 41. | | Completed | Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
Conditions: Williams Syndrome; Angelman Syndrome; Prader-Willi Syndrome; Shprintzen syndrome; Smith-Magenis syndrome; DiGeorge Syndrome; Chromosome Abnormalities |
| 42. | | Recruiting | Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants with Brain Tumors
Condition: Brain Tumors |
| 43. | | Completed | Study of the Nutritional, Metabolic, and Body Composition Profile in Children and Adolescents with Epidermolysis Bullosa
Condition: Epidermolysis Bullosa |
| 44. | | Completed | Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing Enterocolitis in Low Birth Weight Infants
Conditions: Necrotizing Enterocolitis; Sepsis |
| 45. | | Recruiting | Study of Treatment and Metabolism in Patients With Urea Cycle Disorders
Condition: Amino Acid Metabolism, Inborn Errors |
| 46. | | No longer recruiting | Treating High Risk Leukemia with CD40 Ligand & IL-2 Gene Modified Tumor Vaccine.
Condition: Leukemia |
| 47. | | Recruiting | Treating Severe Chronic Epstein-Barr Virus (EBV) Infection with EBV Specific Cytotoxic T Lymphocytes (CTLs)
Condition: Epstein-Barr Virus Infections |
| 48. | | Recruiting | Treatment of B-CLL with Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells
Conditions: Leukemia; Leukemia, B-Cell, Chronic |
| 49. | | Recruiting | Treatment of Chronic Lymphocytic B-Leukemia with IL-2 and CD-40 Autologous Tumor Cells
Condition: Chronic Lymphocytic B-Leukemia |
| 50. | | No longer recruiting | Treatment of Resistant Langerhans Cell Histiocytosis with ENBREL
Condition: Histiocytosis, Langerhans-Cell |
